CNR Institutional Research Information System

BERGHELLA, ANNA MARIA

BERGHELLA, ANNA MARIA  

Istituto di Farmacologia Traslazionale - IFT - Sede Secondaria L'Aquila  

Mostra records
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
Personalized Prevention Strategies to Defeat Cancer 1-gen-2020 Berghella, ANNA MARIA; Aureli, Anna; Canossi, Angelica; Marulli, Giuseppe; Lattanzio, Roberto; Di Gregorio, Giancarlo; Del Beato, Tiziana; Secinaro, Enzo; Patrizia Pellegrini, And
Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer 1-gen-2019 Berghella, ANNA MARIA; Aureli, Anna; Canossi, Angelica; DEL BEATO, Tiziana; Colanardi, Alessia; Pellegrini, Patrizia
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 1-gen-2017 Berghella, ANNA MARIA; Contasta, IDA ANNA; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore Luigi, Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; Pellegrini, Patrizia
Day of Immunology 2015 1-gen-2016 Berghella, ANNA MARIA; Contasta, Ida; Marulli, Giuseppe; D'Innocenzo, Carlo; Garofalo, Ferdinando; Gizzi, Francesca; Bartolomucci, Marco; Laglia, Giacomo; Valeri, Marisa; Gizzi, Mario; Friscioni, Mauro; Barone, Mario; DEL BEATO, Tiziana; Secinaro, Enzo; Pellegrini, Patrizia
Novel Prognostic Biomarkers for Personalized Cancer Treatment 1-gen-2015 CONTASTA IDA ; BERGHELLA ANNA MARIA ; LATTANZIO ROBERTO ; CICCARELLI OSVALDO ; DI GREGORIO GIANCARLO ; VIZIOLI MAURIZIO ; SILVINO MARINO ; LIBERATORE LUIGI LIBORIO ; NAVARRA LUCA ; CATERINO GIAMPAOL ; MONGELLI ANTONIO ; VITTORINI VINCENZO ; CAMPITELLI IRMA ; NUNZIA ANTONUCCI ; DEL BEATO TIZIANA ; SECINARO ENZO AND PELLEGRINI PATRIZIA
The definition of a panel of clinical biomarkers of homeostasis: a new promising tool for prevention and treatment of chronic-degenerative 1-gen-2015 Berghella, ANNA MARIA; Contasta, Ida; Pellegrini, Patrizia
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 1-gen-2014 Berghella A.M.; Contasta I.; Marulli G.; D'Innocenzo C.; Garofalo F.; Gizzi F.; Bartolomucci M.; Laglia G.; Valeri M.; Gizzi M.; Friscioni M.; Barone M.; Del Beato T.; Secinaro E.; Pellegrini P.
A gender-related action of IFNß-therapy was found in multiple sclerosis. 1-gen-2012 Contasta, I; Totaro, R; Pellegrini, P; DEL BEATO, T; Berghella, Am
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 1-gen-2012 Berghella Anna Maria; Pellegrini Patrizia; Contasta Ida
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 1-gen-2012 Berghella, Am; Contasta, I; DEL BEATO, T; Pellegrini, P
Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer. 1-gen-2011 Patrizia Pellegrini; Ida Contasta; Tiziana Del Beato; Fabiana Ciccone;Anna Maria Berghella.
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 1-gen-2011 Berghella, ANNA MARIA; Pellegrini, Patrizia; Contasta, IDA ANNA
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 1-gen-2011 Berghella, Am; Pellegrini, P; Del Beato, T; Ciccone, F; Contasta, I
Classification of cancer stage using the immune system. 1-gen-2010 Pellegrini, P; Contasta, I; Berghella, Am; Del Beato, T; Adorno, D
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 1-gen-2010 Contasta, I; Totaro, R; Berghella, Am; Pellegrini, P; DEL BEATO, T; Carolei, A; Adorno, D
CD30 Molecule, The Immune System and Multiple Sclerosis. 1-gen-2008 BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A; ADORNO D
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 1-gen-2006 Berghella, Am; Contasta, I; Pellegrini, P; DEL BEATO, T; Adorno, D
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 1-gen-2006 Contasta, I; Pellegrini, P; Berghella, Am; DEL BEATO, T; Adorno, D
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 1-gen-2006 PELLEGRINI P; BERGHELLA AM; CONTASTA I; DEL BEATO T; ADORNO D.
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 1-gen-2005 Berghella, Am; Pellegrini, P; Contasta, I; Carolei, A; Adorno, D